RA CAPITAL MANAGEMENT, L.P. XBI Holdings History
RA CAPITAL MANAGEMENT, L.P.'s SPDR Biotech ETF Holding Summary
As of 2025-03-31, RA CAPITAL MANAGEMENT, L.P. held - shares of SPDR Biotech ETF(XBI), totaling N/A. This investment constitutes 0% of their stock portfolio, and RA CAPITAL MANAGEMENT, L.P. now holds 0% of the outstanding SPDR Biotech ETF(XBI) stock.
The initial trade took place in 2024Q4. And since then RA CAPITAL MANAGEMENT, L.P. has made 1 purchases of XBI, at an average price of $96.87, for a total of 1.23 Mil shares. In addition, there have been 1 sales at an average price of $89.38 for 1.23 Mil shares. Based on historical transaction data and XBI's current price of $86.27, RA CAPITAL MANAGEMENT, L.P.'s estimated gain on his XBI holdings is $-9.20 Mil, reflecting a -7.73% gain to date.
RA CAPITAL MANAGEMENT, L.P. XBI ($86.27) Holding Chart
RA CAPITAL MANAGEMENT, L.P. XBI ($86.27) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
